• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV VALVE; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV VALVE; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV410T
Device Problems Obstruction of Flow (2423); Free or Unrestricted Flow (2945)
Patient Problems Failure of Implant (1924); Hydrocephalus (3272)
Event Date 02/12/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Patient information: height (b)(6).When additional information is received a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional "4 year 11 month po overdrain of the valve." additional patient information has been requested.When additional information is received a follow up report will be submitted.All med watch submissions related to this patient are: 3004721439-2019-00056 (this report), 3004721439-2019-00057.
 
Manufacturer Narrative
G1/g2: contact information updated due to expiration of exemption e2014018.Manufacturing site evaluation: manufacturing records show that this progav valve was manufactured by a qualified employee in october 2007.No deviations were identified during assembly.The valve was inspected as article fv410t.The valve has a normal pressure range of 0 to 20 cmws.All required parameters were approved and product specifications met during the manufacturing process.Following final inspection, the valve was sterilized by miethke and released for shipment.Investigation: the valve was received for analysis submersed in an unidentified liquid within a plastic container.Initial visual examination found a deformation of the outer housing of the valve.When measured, the housing deformation was confirmed to be -0.0735 mm, outside the tolerance of 0 +/- 0.02 mm.Testing: permeability testing confirmed the valve is permeable.During adjustment testing, the valve was adjustable to all specified pressures.Brake functionality testing found the brake function does not operate as expected.The results indicate that the rotor no longer performs as required, allowing the valve to self-adjust.To evaluate reports of over drainage, the opening pressure of a valve is typically tested using a miethke computer controlled testing apparatus which simulates cerebral spinal fluid flow.However, in this case that was not possible due to the compromised brake functionality.Finally, the valve was dismantled.A significant build-up of substances (likely protein) was identified at that time.No further anomalies were identified and all other specifications were met.Conclusion: based on our investigation, we were unable to substantiate the report of over-drainage as it was not possible to perform the necessary test, as described above.Although no specific conclusions can be drawn, it is likely that difficulty encountered relates to the deposits observed within the valve during the analysis.We can exclude manufacturing defects at the time of product release as the valve was confirmed to have met all specifications of the final inspection.As described in our literature, this is a known, inherent risk of hc-therapy involving shunt implants and no manufacturing relationship is established.The cause of the housing deformation could not be determined with certainty.Significant outside pressure, for example excessive force from a progav adjustment tool or by a fall or impact to the patient's head, can compromise the integrity of the valve.No manufacturing relationship is established.Reports of this type will continue to be monitored.At this time, no trend for reports of this type has been identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV VALVE
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8384019
MDR Text Key137671937
Report Number3004721439-2019-00056
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K103003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2012
Device Model NumberFV410T
Device Catalogue NumberFV410T
Device Lot Number4501220299
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/14/2019
Distributor Facility Aware Date02/15/2019
Device Age12 YR
Date Manufacturer Received02/27/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age23 YR
Patient Weight30
-
-